EMA – Improved scientific advice for medicines for public health threats including antimicrobial resistance
EMA’s Emergency Task Force (ETF) is improving its approach to scientific advice for the most promising medicines and vaccines under development for public health threats. Under the new process, developers of medicines falling within the...





